Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 20,200
+100 (0.50%)
Aug 3, 2026, 3:30 PM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 140.77 billion as of August 3, 2026. Its market cap has decreased by -14.59% in one year.
Market Cap
140.77B
Enterprise Value
-85.22B
Revenue
64.38B
Ranking
n/a
PE Ratio
116.65
Stock Price
20,200.00
ChartMarket Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 140.77B, an increase of 698.70%. That is a compound annual growth rate of 7.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 140.77B | -7.34% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong Sung Bio Pharm.Co.,Ltd. | 162.33B |
| Daewon Pharmaceutical | 160.32B |
| Hana Pharm | 154.09B |
| Daihan Pharmaceutical | 154.06B |
| Ilyang Pharmaceutical Co.,Ltd | 151.11B |
| Hyundai Pharmaceutical | 148.35B |
| AptaBio Therapeutics | 141.87B |
| Jeil Pharmaceutical Co.,Ltd | 141.20B |